I think this company has a bright future.
Could some one answer this for me, on the EchoIQ website it says:
*EchoSolv™ phenotyping capabilities are available in New Zealand, with regulatory clearance planned for the US and Australia regions
So how many cardiologists, hospitals etc are using this in NZ?
Are we generating any revenue from NZ?
Ann: Echo IQ Webinar 27 May 2024 - Recording Available, page-4
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $77.95M | |||
| Open | High | Low | Value | Volume |
| 15.0¢ | 15.0¢ | 14.5¢ | $77.27K | 531.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 19718 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 158902 | 3 |
View Market Depth
| Last trade - 15.54pm 19/08/2024 (20 minute delay) ? |
| EIQ (ASX) Chart |